Tingting Yang
Hangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Prognostic impact of clinico-genetic characteristics and donor types in NPM1-mutated AML undergoing allogeneic hematopoietic stem cell transplantation.
Journal: Cell transplantation
Published: February 12, 2026
Peroxymonocarbonate as a green oxidant for the efficient degradation of tetracycline.
Journal: Environmental technology
Published: February 03, 2026
Emergence of co-resistance to imipenem/relebactam and ceftazidime/avibactam in clinical Klebsiella pneumoniae ST11 clone due to KPC-2 N132S and CTX-M-65 S130G/P167S substitutions.
Journal: Antimicrobial agents and chemotherapy
Published: November 04, 2025
Targeting Wnt/β-catenin signaling enhances the efficacy of anti-CD38 immunotherapy in multiple myeloma.
Journal: Neoplasia (New York, N.Y.)
Published: September 10, 2025
Safety and efficacy of CD19-targeted CAR-T-cell therapy for patients with relapsed or refractory TCF3-PBX1 fusion gene-positive B-ALL.
Journal: Hematology (Amsterdam, Netherlands)
Published: September 03, 2025
Strategies to Enhance CAR-T Cell Persistence in Hematologic Malignancies: From Molecular Design to Clinical Optimization.
Journal: American journal of hematology
Published: July 26, 2025
Iron-mediated ferroptosis impairs CAR-T cell function and antitumor efficacy.
Journal: Nature cancer
Published: July 12, 2025
NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study.
Journal: Transplantation and cellular therapy
Published: May 17, 2025
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma.
Journal: Bone marrow transplantation
Published: April 12, 2025
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma.
Journal: Journal for immunotherapy of cancer
Published: March 06, 2025
Sequential allogeneic HSCT after CAR-T therapy for relapsed/refractory acute lymphoblastic leukemia patients: A long-term follow-up result.
Journal: Journal of advanced research
Published: November 16, 2024
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia.
Journal: Experimental hematology & oncology
Published: October 16, 2024
Last Updated: 09/26/2026